Nuheara IQBuds Max vs Resound Vivia 9 60S microRIE

The Nuheara IQBuds Max is a budget-priced OTC hearing aid that earns a B grade with a SoundScore of 3.4/5 in our lab testing. At $499, it sits in the affordable tier of the OTC category, ranking #46 of 65 devices tested. The standout performance area for the IQBuds Max is music streaming, which scores a strong 4.3/5—significantly above the category average by 2.38 points. This makes it one of the better choices in the OTC space for users who prioritize audio entertainment alongside hearing assistance. However, speech performance presents a mixed picture: speech in quiet scores 2.0/5, falling 0.78 points below the category average, while speech in noise scores a low 1.5/5, though this is essentially at the category average. Own-voice comfort is mixed at 2.2/5, sitting slightly below the category average. Feedback handling scores a solid 3.4/5 in absolute terms, though this is 1.14 points below the category average of 4.54/5. The device features rechargeable batteries and supports both iPhone and Android streaming with hands-free capability. The IQBuds Max is best suited for users who want an affordable entry into amplification with strong music streaming performance, but who have modest expectations for speech clarity improvement. Those prioritizing speech understanding may want to consider higher-ranked alternatives in the same price range, such as the Elehear Beyond or Apple AirPods Pro 2.

The Resound Vivia 9 60S microRIE is a premium prescription behind-the-ear hearing aid released in 2025, currently available at $3,798. In HearAdvisor's lab testing, it earned a B grade with a SoundScore of 3.9/5, ranking #27 of 36 prescription hearing aids tested. This device demonstrates a mixed performance profile in our testing. Own-voice comfort is a notable strength, scoring 3.4/5—a solid result that sits 0.65 points above the category average, which may appeal to users sensitive to the hollow or boomy sound of their own speech. Speech clarity in quiet environments also performs well at 3.4/5, slightly above the category average. However, the Vivia 9 shows significant limitations in challenging listening situations. Speech in noise scored just 1.1/5, falling 0.81 points below the prescription hearing aid average—a substantial gap that suggests difficulty in restaurants, group conversations, or other noisy environments. Feedback handling, while strong in absolute terms at 4.2/5, still lands 0.51 points below what we typically see from prescription devices. Music streaming quality is mixed at 2.6/5, essentially matching the category average. At this premium price point, the Vivia 9 faces stiff competition. Several same-priced alternatives, including the Phonak Sphere Infinio and Oticon Intent, achieved notably higher overall scores in our testing. Consumers prioritizing noise performance may want to explore these options or consider lower-priced alternatives like the Sennheiser All Day Clear that delivered stronger overall results in our lab.